0 Комментарии
0 Поделились
411 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Antibody Drug Conjugate Market Analysis, Growth Trends & Forecast to 2033The Antibody-Drug Conjugates (ADC) market is experiencing significant growth, driven by the rising demand for targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As of 2025, the global ADC market is valued at over USD 8 billion, with projections estimating it will surpass USD 20 billion by 2030, fueled...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Antibody Drug Conjugate Market Analysis, Growth Trends & Forecast to 2033The Antibody-Drug Conjugates (ADC) market is experiencing significant growth, driven by the rising demand for targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As of 2025, the global ADC market is valued at over USD 8 billion, with projections estimating it will surpass USD 20 billion by 2030, fueled...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Antibody Drug Conjugates Market Size And Forecast to 2033The Antibody-Drug Conjugates (ADC) market is experiencing significant growth, driven by the rising demand for targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As of 2025, the global ADC market is valued at over USD 8 billion, with projections estimating it will surpass USD 20 billion by 2030, fueled by...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Antibody-Drug Conjugate (ADC) Oncology Market Overview: Key Drivers and ChallengesAntibody-Drug Conjugate (ADC) Oncology Market Summary: According to the latest report published by Data Bridge Market Research, the Antibody-Drug Conjugate (ADC) Oncology Market CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of...0 Комментарии 0 Поделились 214 Просмотры 0 предпросмотр
-
Antibody-Drug Conjugate (ADC) Oncology Market Overview: Key Drivers and ChallengesExecutive Summary Antibody-Drug Conjugate (ADC) Oncology Market: Growth Trends and Share Breakdown CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of 10.80% during the forecast period In this competitive marketplace, businesses are...0 Комментарии 0 Поделились 545 Просмотры 0 предпросмотр
-
Antibody-Drug Conjugate (ADC) Oncology Market: Trends and Growth OpportunitiesExecutive Summary Antibody-Drug Conjugate (ADC) Oncology Market Research: Share and Size Intelligence CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of 10.80% during the forecast period The scope of this Antibody-Drug Conjugate...0 Комментарии 0 Поделились 643 Просмотры 0 предпросмотр
-
Antibody-Drug Conjugates (ADC) Market Size, Share & Growth Report 2034 | CAGR 13.5%The Global Antibody-Drug Conjugates (ADC) Market Report offers a comprehensive evaluation of the antibody-drug conjugates industry, delivering valuable insights into business strategies, current market trends, and both qualitative and quantitative assessments. The study provides an in-depth analysis of critical market aspects, including key growth drivers, restraints, opportunities, risks, and...0 Комментарии 0 Поделились 265 Просмотры 0 предпросмотр
-
ADC Contract Manufacturing Market Experiencing Rapid GrowthThe Antibody Drug Conjugate (ADC) contract manufacturing market is at the forefront of the precision medicine revolution. Known as "biological missiles," ADCs combine the targeting specificity of monoclonal antibodies with the cell-killing potency of cytotoxic payloads. Because the production of these therapies requires a complex fusion of biologic manufacturing and high-potency...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek